All News #Library
Biotech
Civica To Introduce Long-Acting Insulin Glargine In US
20 Oct 2025 //
PR NEWSWIRE
Biocon Biologics And Civica Launch Private-Label Insulin Glargine
18 Oct 2025 //
INDPHARMAPOST
Gov Youngkin Announces $3 M Grant for Civica Insulin Program
08 Aug 2025 //
PR NEWSWIRE
Biocon Biologics and Civica Expand Insulin Aspart Access in
08 Mar 2025 //
PR NEWSWIRE
Civica Rx draws $50M from California to produce low-cost insulin
20 Mar 2023 //
FIERCE PHARMA
California Selects Civica Rx as Its Insulin Manufacturing Partner
18 Mar 2023 //
BUSINESSWIRE
Civica Partners with Ypsomed for Insulin Injection Pen
07 Feb 2023 //
CONTRACT PHARMA
Civica Welcomes Ypsomed as Injection Pen Partner for Its Insulin Initiative
31 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support